FGF19 and FGF21: In NASH we trust.

Mol Metab · 2021 · PMC8085573 · PMID 33383173

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a recent study conducted in obese subjects, a single dose of the bispecific anti-FGFR1/KLB agonist antibody, BFKB8488A showed a trend toward reduction in preference for sweet taste and carbohydrate intake [ 98 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.